Adicet Bio, Inc. (ACET)
8.10
+0.34
(+4.38%)
USD |
NASDAQ |
Jun 17, 16:00
8.03
-0.07
(-0.86%)
After-Hours: 20:00
Adicet Bio Total Liabilities (Quarterly) : 29.32M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 29.32M |
| December 31, 2025 | 33.14M |
| September 30, 2025 | 31.34M |
| June 30, 2025 | 29.60M |
| March 31, 2025 | 29.82M |
| December 31, 2024 | 33.61M |
| September 30, 2024 | 34.43M |
| June 30, 2024 | 33.73M |
| March 31, 2024 | 34.29M |
| December 31, 2023 | 37.12M |
| September 30, 2023 | 38.58M |
| June 30, 2023 | 38.57M |
| March 31, 2023 | 38.76M |
| December 31, 2022 | 38.35M |
| September 30, 2022 | 36.64M |
| June 30, 2022 | 36.64M |
| March 31, 2022 | 29.37M |
| Date | Value |
|---|---|
| December 31, 2021 | 35.81M |
| September 30, 2021 | 39.97M |
| June 30, 2021 | 40.44M |
| March 31, 2021 | 45.81M |
| December 31, 2020 | 44.01M |
| September 30, 2020 | 33.47M |
| June 30, 2020 | 3.598M |
| March 31, 2020 | 2.589M |
| December 31, 2019 | 141.95M |
| September 30, 2019 | 12.20M |
| June 30, 2019 | 9.717M |
| March 31, 2019 | 4.624M |
| December 31, 2018 | 5.735M |
| September 30, 2018 | 8.086M |
| June 30, 2018 | 11.62M |
| March 31, 2018 | 6.862M |
| December 31, 2017 | 5.502M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Savara, Inc. | 45.61M |
| Vericel Corp. | 129.40M |
| Biogen, Inc. | 10.83B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 169.38M |
| Shareholders Equity (Quarterly) | 140.06M |
| Debt to Equity Ratio | 0.0992 |
| Current Ratio | 7.655 |
| Net Debt Paydown Yield | 1.02% |